Harvest Investment Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-807
Closed -$205K 239
2021
Q4
$205K Sell
807
-2,780
-78% -$813K 0.09% 248
2021
Q3
$1.38M Sell
3,587
-493
-12% -$182K 0.56% 50
2021
Q2
$958K Sell
4,080
-13,777
-77% -$2.46M 0.4% 70
2021
Q1
$2.34M Sell
17,857
-5,300
-23% -$768K 1.05% 16
2020
Q4
$2.42M Sell
23,157
-907
-4% -$91.8K 1.24% 16
2020
Q3
$1.7M Buy
24,064
+122
+0.5% +$8.51K 0.98% 23
2020
Q2
$1.54M Buy
+23,942
New +$1.31M 0.91% 23

Other funds holding MRNA

Harvest Investment Services's MRNA Position: Q1 2022 in Review

Harvest Investment Services sold out of Moderna (MRNA) in Q1 2022, closing a stake of 807 shares — an estimated $205K sold.

Harvest Investment Services first reported a position in MRNA in Q2 2020 and held it in 7 quarters. The position peaked at $2.42M in Q4 2020. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Harvest Investment Services reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Harvest Investment Services sold 807 Moderna shares in Q1 2022, an estimated $205K.
  • Harvest Investment Services first reported a position in Moderna in Q2 2020 and held it in 7 quarters.
  • Harvest Investment Services's Moderna position peaked at $2.42M in Q4 2020.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Harvest Investment Services's 13F filing for Q1 2022, filed 3 May 2022.